What are the Treatment Options for Patients with FUS-DDIT3 Positive Tumors?
Treatment options for patients with FUS-DDIT3 positive tumors often include a combination of surgery, radiation therapy, and chemotherapy. The identification of the FUS-DDIT3 fusion gene may also open avenues for targeted therapies. Ongoing research is focused on developing novel therapeutic agents that specifically target the molecular pathways affected by the fusion protein.
